Transportation for Cancer Care Navigation Tool for Reducing Travel Barriers Among Patients With Solid Tumors Receiving Radiation Therapy
Part of paid clinical trials in Atlanta, Georgia.
- Sponsor
- Emory University
- Study ID
- NCT06541158
- Status
- Recruiting
Conditions
- Malignant Solid Neoplasm
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Best Practice — OTHERReceive usual care
- Discussion — OTHERParticipate in a CAB
- Educational Intervention — OTHERReceive PAF pamphlet
- Health Promotion and Care — BEHAVIORALReceive the TRACT program
- Media Intervention — OTHERReceive transportation awareness brief video
- Questionnaire Administration — OTHERAncillary studies
Study Details
This clinical trial evaluates whether the Transportation for Cancer Care Navigation Tool (TRACT) can reduce travel barriers among patients with solid tumors receiving radiation therapy. It is estimated that 20-30% patients with cancer experience travel-related barriers for cancer care. This is a particular problem for patients with radiation therapy as these patients frequently receive multiple treatment cycles, which often require daily treatment for multiple weeks or months. Addressing travel barriers has been a prerequisite for cancer care as travel barriers negatively influence cancer treatment adherence and cancer care outcomes, such as survival and quality of life. The TRACT program may help reduce travel barriers and therefore promote health equity among patients with solid tumors receiving radiation therapy.
Key Dates
- Start date
- Nov 6, 2024
- Status verified
- May 2026
- Primary completion
- May 15, 2028
- Completion
- May 15, 2028
Study Design
- Enrollment
- 76 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Stage I (CAB)Participants meet with the study research team to develop and refine the TRACT program.
- Experimental: Stage II Group I (TRACT program)Patients receive the TRACT program consisting: of 1) Screening of travel barriers; 2) Awareness of transportation obstacles and resources using videos, 3) Assistance with transportation resource application and utilization, and 4) Alignment of community resources to navigate individualized transportation support by the trained travel navigator for 3 months.
- Active Comparator: Stage II Group II (usual care, video, pamphlet)Patients receive usual care with PAF pamphlet for 3 months.
Primary Outcome Measure
Feasibility of screening patients for the Transportation for Cancer Care Navigation Tool (TRACT) program [ Time Frame: At T0 (pre-intervention) and T1 (3 months post-intervention) ]
Locations (4)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Emory Proton Therapy Center | Atlanta | Georgia | 30308 | |
| Emory Saint Joseph's Hospital | Atlanta | Georgia | 30342 | |
| Emory University Hospital Midtown | Atlanta | Georgia | 30308 | Maria Norman |
| Emory University Hospital/Winship Cancer Institute | Atlanta | Georgia | 30322 | Jinbing Bai (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Atlanta, GA
Related Studies
- Project: Every Child for Younger Patients With CancerRecruiting · Children's Oncology Group · Birmingham, Alabama
- Collection and Storage of Tissue and Blood Samples From Patients With CancerRecruiting · National Cancer Institute LAO · Birmingham, Alabama
- Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVOPHASE1 · Recruiting · National Cancer Institute (NCI) · Birmingham, Alabama
- Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid TumorsRecruiting · SWOG Cancer Research Network · Anchorage, Alaska